CAGRILINITIDE 10MG is a high-dose amylin receptor agonist peptide, currently under investigation for its powerful role in appetite suppression, gastric emptying delay, and glucose regulation. As a synthetic analog of human amylin, this compound works synergistically with GLP-1 analogs, and is being explored for its potential to deliver significant weight loss outcomes in advanced obesity research models.
The 10mg format is ideal for extended-duration studies, high-tolerance research models, or combination peptide protocols involving Semaglutide or Tirzepatide.
